CBD, short for cannabidiol, has one firmly established medical use and several promising but less proven benefits. It is FDA-approved for treating severe seizure disorders in children and adults, where it reduces seizure frequency by roughly 37% to 44% compared to placebo. Beyond that, research suggests CBD may help with chronic pain, anxiety, and inflammatory skin conditions, though the evidence varies in strength depending on the condition.
Seizure Reduction: The Only FDA-Approved Use
The clearest benefit of CBD is in epilepsy. The FDA approved a pharmaceutical-grade CBD oral solution for three rare and severe seizure disorders: Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex. It’s approved for patients one year of age and older.
The clinical trial data is substantial. In Lennox-Gastaut syndrome, patients taking CBD experienced a 42% to 44% reduction in drop seizures, compared to a 17% to 22% reduction in those on placebo. For Dravet syndrome, convulsive seizures dropped by 39% versus 13% on placebo. And for tuberous sclerosis, seizure frequency fell by 43% compared to 20% on placebo. Nearly all participants in these trials were already taking other seizure medications, so CBD provided additional benefit on top of existing treatment.
Chronic Pain Relief
Pain management is the most common reason people try CBD, and the research is cautiously encouraging. A systematic review of clinical studies found that most trials reported pain reductions ranging from 42% to 66%, though these figures came from studies using CBD alone or CBD combined with THC. Pain was typically measured through self-reporting scales, which introduces some subjectivity.
Not every study showed a benefit. Three studies in the review found no significant improvement, and one had mixed results. The types of pain studied varied widely, from nerve pain to inflammatory conditions, making it difficult to say exactly which kinds of pain respond best. Still, for people dealing with persistent pain who haven’t found relief through conventional options, the overall trend in the research is positive.
Anxiety and Stress
CBD interacts with the body’s endocannabinoid system and appears to influence serotonin signaling, the same brain pathway targeted by many conventional anti-anxiety medications. Animal research has shown that CBD can block long-lasting behavioral effects of stress exposure, likely through its interaction with serotonin receptors.
Human studies on anxiety have used doses ranging from as low as 6 mg to as high as 400 mg, which makes it hard to pin down an ideal amount. The wide range reflects how early this research still is. Many people report that CBD helps them feel calmer, but the clinical evidence hasn’t yet converged on specific doses for specific anxiety conditions the way it has for seizure disorders.
Skin Conditions
Topical CBD has drawn attention for acne, psoriasis, and eczema, and the biological mechanisms are surprisingly well mapped out even if large clinical trials are still limited.
For acne, CBD reduces oil production in skin cells and fights inflammation triggered by the bacteria commonly associated with breakouts. It essentially slows down the overactive oil glands while calming the redness and swelling that make acne visible.
For psoriasis, CBD targets several of the inflammatory signals that drive the disease, including the specific immune pathway (the TNF/IL-23/IL-17 axis) that causes skin cells to multiply too rapidly. It also appears to normalize the behavior of keratinocytes, the skin cells that build up into thick, scaly patches in psoriasis.
For eczema, CBD boosts the body’s own anti-inflammatory compounds by slowing the breakdown of anandamide, a naturally occurring molecule that reduces pain and inflammation. It also interacts with receptors involved in itch signaling and helps restore the skin barrier that eczema disrupts. These pathways are well established in lab research, though translating them into reliable clinical outcomes for patients is still a work in progress.
Neuroprotection
Some of the most intriguing CBD research involves neurodegenerative conditions like Parkinson’s disease, though this work is still in early stages and conducted in animal models rather than humans. In laboratory organisms engineered to mimic Parkinson’s, CBD reduced the degeneration of dopamine-producing neurons by up to 71% at the highest doses tested. It also decreased the toxic clumping of alpha-synuclein, a protein that accumulates in Parkinson’s patients’ brains, by up to 70%.
CBD achieved these effects partly through antioxidant activity, reducing harmful reactive oxygen species by up to 57% in damaged nerve cells. It also boosted the cell’s own protein-cleanup machinery and its natural antioxidant defenses. These are promising signals, but animal model results frequently fail to translate directly to humans, so this remains a “watch this space” area of research.
Sleep: A Complicated Picture
Many people use CBD as a sleep aid, but the clinical evidence is more nuanced than the marketing suggests. In a controlled trial of 20 patients with insomnia disorder, a single dose of 200 mg CBD combined with 10 mg THC actually decreased total sleep time by about 24.5 minutes compared to placebo. It also reduced time spent in REM sleep. That’s the opposite of what most people expect from a product sold as a sleep supplement.
This doesn’t necessarily mean CBD is bad for sleep. The study used a single acute dose rather than consistent nightly use, and the combination with THC complicates matters. Some people may experience relaxation from CBD that indirectly helps them fall asleep, particularly if anxiety is what keeps them awake. But the idea that CBD is a straightforward sleep aid isn’t well supported by rigorous trial data.
Drug Interactions to Know About
CBD affects the liver enzymes that metabolize a wide range of medications. It inhibits several key enzyme families responsible for breaking down drugs in your body. In practical terms, this means CBD can cause other medications to build up to higher-than-expected levels in your bloodstream.
A review of 53 drug substrates found that CBD increased blood levels of 31 of them. This is especially relevant if you take blood thinners, certain heart medications, or anti-seizure drugs (ironically, given CBD’s use in epilepsy, dose adjustments of other medications are common). Because CBD is widely viewed as a natural supplement rather than a drug, many people don’t mention it to their pharmacist or prescriber, which creates a real risk of unintended interactions, particularly for anyone taking multiple medications.
Legal Status in the United States
CBD’s legal status has shifted recently. Under the 2018 Farm Bill, hemp products containing less than 0.3% delta-9 THC were federally legal, which opened the door for the CBD market to explode. However, in November 2025, Congress passed a new agriculture appropriations act that reimposed federal controls over certain hemp products. The FDA still has not established a clear regulatory framework for CBD as a dietary supplement, which means quality and labeling accuracy vary significantly between products. Third-party testing remains the most reliable way to verify what you’re actually getting.